Prostate Cancer Program

  • Recent data shows that men with prostate cancer have a relative five-year survival rate of nearly 100% and a 10-year survival rate of 91%.
  • Prostate cancer often has no early symptoms. Later-stage symptoms include a delayed or slowed urine stream, strain to empty the bladder, blood in the urine, and dribbling or dripping of urine. The good news is that prostate cancer usually grows slowly.
  • People at-risk for prostate cancer include African-American men, men older than 60, men with a family history of prostate cancer. Others at-risk include farmers, painters, tire plant workers, obese men, and men who eat a high-fat diet.
  • Prostate cancer is less common in vegetarians.
  • Holden offers a prostate cancer support group.

If you have prostate cancer, you want the most comprehensive expertise available. 

At University of Iowa Holden Comprehensive Cancer Center, our highly experienced physicians and staff are dedicated to taking care of you, not just your cancer. Our team focuses on every aspect of prostate cancer, including what your life will be like when your treatment is complete. Our clinicians are also top researchers finding new and innovative treatments and therapies as well as what it takes to get you back to your life. We are always searching for ways to make the best cancer treatments even better.

Why Choose Holden For Your Care?

Patients of Holden Cancer Center benefit from a team-based approach that puts each patient at the center. At Holden, experts in specific cancer types—including a genetic counselor certified and specializing in cancer genetic counseling—is part of this team.

Holden patients also benefit from medical advances that take into account an individual’s tumor, genes, environment, and lifestyle to diagnose and treat their specific types of cancer. Known as personalized, or precision medicine, this highly specialized approach is part of Holden’s commitment to providing life-changing medical treatments and care.

Services That Set Us Apart

  • Experts focused on prostate cancer. Our team of specialists focuses only on cancers of the urinary system. They understand the disease and know about the most recent treatment option from innovative surgeries to chemotherapy to radiation therapy.
  • Robotic and standard surgical options. Holden Comprehensive Cancer Center at the University of Iowa offers unique surgical procedures for prostate cancer patients. In fact, we were the first hospital in Iowa to offer robotic radical prostatectomy to our patients.
  • Quality of life expertise. We understand that as a prostate cancer patient, you may have side effects from treatments that can change the quality of your life—from being able to use the bathroom to your sexual health. We have been studying these challenges and offering solutions for decades.
  • Innovative clinical trials. We not only offer access to the most recent treatment methods and therapies, but our physicians are also prostate cancer researchers, placing them at the forefront of the latest breakthroughs.
  • New infusion suite just for you. Our infusion suite was designed with patient input to create a comfortable, welcoming environment. Take our virtual tour

Our Approach

Holden Comprehensive Cancer Center is the only institution in Iowa and one of only 45 nationwide to be designated a Comprehensive Cancer Center by the National Cancer Institute (NCI). Of the approximately 1500 cancer centers and programs in the United States, NCI-designated Comprehensive Cancer Centers are rated in the top 4 percent nationally.

Our medical teams have met strict guidelines in clinical, laboratory, and population-based research.

As members of an NCI-designated Comprehensive Cancer Center, our doctors, nurses, and staff are among the nation’s leaders in cancer research, education, prevention, and outreach. Our experience and expertise guides the cancer care we provide to patients like you.

Clinical Trials and Research

This is an exciting time in the world of cancer research. Our physicians are knee-deep in this research, and they understand new developments to treat prostate cancer.

Clinical trials are research studies that test out the latest treatments and drugs that are not yet available to the public. These new treatments have the potential to improve your quality of life or increase your chances of survival. Holden offers a number of clinical trials for prostate cancer.

See all of the clinical trials at Holden Comprehensive Cancer Center.

Support Our Mission

Our work is made possible in part by the support of donors through charitable giving. Friends of Holden Comprehensive Cancer Center can become partners in our efforts to control and ultimately cure cancer. Learn how you can help us make a difference for cancer patients.

Patient Stories

Lone Tree postal worker, Brad Woodiwiss benefited from robotic surgery, going home from the hospital the next day and getting back to work in 6 weeks. Now he is cancer free.

Prostate Cancer Care Team

We bring together experts from different areas of medicine to work together as a team called a multidisciplinary oncology group, focused on a specific cancer type, such as prostate cancer.

This team of specialists—surgical oncologists, medical oncologists, radiation oncologists, radiologists, pathologists, pharmacists, plastic and reconstructive surgeons, genetics counselors, nurses, and others—works together to design a treatment plan that is tailored to your cancer and your specific treatment needs.

Co-Leader: James Brown, MD (Surgeon)
Co-Leader: Daniel Vaena, MD (Medical Oncology)

Research Nurses

  • Michelle Arnold, RN
  • Susan Butcher, RN
  • Janan Geick-Miller, RN
  • Mary Schall, RN
  • Jill Wegeman, RN
  • Pam Zehr, RN